Allergic Rhinitis Clinical Trial
Allergic rhinitis is a complex chronic inflammatory disease, it always presents with nasal
obstruction, nasal itching, sneezing and runny nose. Whether in adults or children, rhinitis
is a complex disease. The prevalence of allergic rhinitis in Taiwan is about 24-29%. Taiwan
is a developing country. It is a hot and humid country. In developing countries,
industrialization, air pollution makes the constantly increasing number of patients with
rhinitis. Penghu in 1994 for children aged 7 to 14 by the study found that among 7599
people, 1766 people have allergic rhinitis, about 23.2%. Allergic rhinitis is a complex
chronic disease. So, it become a diagnostic challenge, its prevalence always underestimated.
The prevalence of rhinitis has increased in recent years. The phenomenon of underestimate is
caused by variety of personal and environmental factors. Allergic rhinitis had increased
direct and indirect social and economic burden.
Geographic tongue is a benign tongue performance. Geographic tongue has been reported their
relevance to allergy. Geographic tongue is a chronic tongue situation. The causes of
geographic tongue still remains unknown. Allergic rhinitis is a diagnostic challenge to
clinicians. The investigators hope that geographic tongue could play a role in the
diagnostic of allergic rhinitis. The prevalence of geographic tongue in the United States is
about 1.8%, white Americans and Mexicans have a higher incidence rate. This study will
investigate the relevance between allergic rhinitis and geographic tongue. The investigators
will analyze the relevant gender, age, severity of inspection reports. The research results
wound provide an important reference to the diagnosis of allergic rhinitis.
n/a
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05080322 -
Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis
|
Phase 4 | |
Recruiting |
NCT06028490 -
A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.
|
Phase 2 | |
Completed |
NCT04388358 -
Traditional Chinese Medicine for the Treatment of Perennial Allergic Rhinitis on Gut Microbiota and Immune-modulation
|
N/A | |
Recruiting |
NCT04202263 -
Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline
|
Phase 2 | |
Completed |
NCT04078009 -
Standardising Nasal Allergen Challenge in Adult With Hay Fever
|
N/A | |
Completed |
NCT03644680 -
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
|
N/A | |
Completed |
NCT04541004 -
Adolescent Mite Allergy Safety Evaluation
|
Phase 3 | |
Recruiting |
NCT05378594 -
HDM and Silver Birch NAC Standardisation
|
N/A | |
Not yet recruiting |
NCT05684380 -
Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)
|
Phase 3 | |
Completed |
NCT02910401 -
Clinical Response to Rhinovirus Challenge
|
Phase 2 | |
Completed |
NCT02943720 -
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
|
Phase 2 | |
Not yet recruiting |
NCT01014325 -
Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy
|
Phase 3 | |
Completed |
NCT02556801 -
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
|
Phase 2 | |
Not yet recruiting |
NCT02233426 -
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
|
N/A | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT01918956 -
PURETHAL Birch RUSH Study
|
Phase 4 | |
Completed |
NCT01946035 -
Alpha-Blockers in Allergic Rhinitis (MAN 01)
|
Phase 4 | |
Completed |
NCT01682070 -
SUBLIVAC FIX Phleum Pratense DT/DRF
|
Phase 2 | |
Completed |
NCT01439815 -
An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo
|
Phase 4 | |
Completed |
NCT01438463 -
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis
|
Phase 2 |